Pfm Health Sciences, LP Shattuck Labs, Inc. Transaction History

Pfm Health Sciences, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$17.57 - $28.95 $5.74 Million - $9.46 Million	-326,813 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$27.92 - $52.5 $1.68 Million - $3.15 Million	-60,000 Reduced 15.51%	326,813 $9.19 Million
Q4 2020 Feb 19, 2021	BUY	$19.0 - $57.61 $6.21 Million - $18.8 Million	326,813 Added 544.69%	386,813 $16.2 Million
Q4 2020 Feb 16, 2021	BUY	$19.0 - $57.61 $1.14 Million - $3.46 Million	60,000 New	60,000 $3.15 Million

28.8M

300

1.2K

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $50.4M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.